Sign in

Michael Cilento

@drcilento.bsky.social
229 followers 196 following 14 posts

I am a medical oncologist & PhD candidate. Passionate about precision oncology and prostate cancer. Research at SAiGENCI.

PostsRepliesMedia
Reposted by Michael Cilento
American Society of Clinical Oncology @ascocancer.bsky.social · 23/02/2026
The full abstracts are available for #GU26! Read about the emerging treatment advances and strategies in GU cancers—and their impact on patient care—that will be featured in just a few days at the 2026 ASCO Genitourinary Cancers Symposium. View the abstracts: bit.ly/4tMkIW5
041
Michael Cilento @drcilento.bsky.social · 28/11/2025
Proud to co-author this review with Prof Chris Sweeney @chrissweens1.bsky.social, whose leadership and dedication continue to advance care for people affected by prostate cancer. Published in @natrevclinonc.nature.com. #prostatecancer #pcsm
021
Michael Cilento @drcilento.bsky.social · 02/05/2025
www.nature.com/articles/s41...
nature.com
Geographic and age variations in mutational processes in colorectal cancer - Nature
Nature - Geographic and age variations in mutational processes in colorectal cancer
110
Michael Cilento @drcilento.bsky.social · 13/02/2025
www.thelancet.com/journals/lan...
thelancet.com
Overall survival and quality of life with [177Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer (ENZA-p): secondary outcomes from a multicen...
The addition of [177Lu] Lu-PSMA-617 to enzalutamide was associated with improved survival and some aspects of HRQOL in patients with high-risk metastatic castration-resistant prostate cancer. Our find...
220
Michael Cilento @drcilento.bsky.social · 30/01/2025
www.sciencedirect.com/science/arti...
sciencedirect.com
Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential150 Trial
In the phase 3 IPATential150 trial, ipatasertib addition to abiraterone significantly reduced the risk of disease progression in men with metastatic c…
020
Reposted by Michael Cilento
Kat Morel @katmorel.bsky.social · 16/01/2025
Our paper is out in @jclinical-invest.bsky.social 🎉 A great piece of collaborative science with Leigh Ellis and Chris Sweeney, looking at the role of tristetraprolin in #prostatecancer phenotypic plasticity (plus journal cover art by yours truly!) www.jci.org/articles/vie...
jci.org
JCI - Low tristetraprolin expression activates phenotypic plasticity and primes transition to lethal prostate cancer in mice
073
Reposted by Michael Cilento
Eli Van Allen @vanallenlab.bsky.social · 04/12/2024
Congrats to Larry, Aram et al on latest prostate cancer immunology effort, now out in @natureportfolio.bsky.social - fun collaboration + more to come! @danafarber.bsky.social @ucsfcancer.bsky.social www.nature.com/articles/s41...
nature.com
Evolution of myeloid-mediated immunotherapy resistance in prostate cancer - Nature
Single-cell profiling of human prostate cancer and studies in mouse models show that macrophages expressing SPP1 mediate immunotherapeutic resistance through adenosine pathway activation and repr...
0224
Michael Cilento @drcilento.bsky.social · 24/11/2024
Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer. doi.org/10.1038/s414...
doi.org
Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer - Nature Communications
The prostate cancer tumour microenvironment in the context of treatment remains to be explored. Here, single-cell RNA-sequencing and spatial transcriptomics analysis of samples at multiple treatment p...
070
Michael Cilento @drcilento.bsky.social · 24/11/2024
doi.org/10.1007/s004...
doi.org
Spatial transcriptomics in cancer research and potential clinical impact: a narrative review - Journal of Cancer Research and Clinical Oncology
Spatial transcriptomics (ST) provides novel insights into the tumor microenvironment (TME). ST allows the quantification and illustration of gene expression profiles in the spatial context of tissues,...
010
Reposted by Michael Cilento
Ravi Madan @ravimadan.bsky.social · 16/11/2024
Ok Not really sure what I’m doing but this #ProstateCancer starter pack has been created It is meant to be INclusive so please let me know if you know anyone who wants so “join” @asharpmedonc.bsky.social @nimasharifimd.bsky.social @alison-tree.bsky.social @profiand.bsky.social go.bsky.app/ANw3D3j
233818
Reposted by Michael Cilento
Ian Davis @profiand.bsky.social · 16/11/2024
GU starter pack… started! Let me know if you want to be added. go.bsky.app/DtoXvaD #Genitourinary #Oncology #GUonc #ProstateCancer #KidneyCancer #Urothelial #BladderCancer #PenileCancer #TesticularCancer #pcsm #kcsm #blcsm #tcsm #Medsky #Medtwitter
Genitourinary oncology starter pack

https://go.bsky.app/DtoXvaD
365420
Reposted by Michael Cilento
Popular Science @popsci.com · 16/11/2024
co-signed.
24910
Michael Cilento @drcilento.bsky.social · 04/09/2024
🌟Support SAiGENCI Cancer Research and help fund groundbreaking science! Plus, you can double your impact through matched giving on Giving Day! Let's make a lasting impact together. 💪🌍 #UoAGivingDay #UAMakeHistory Donate now!
000
Michael Cilento @drcilento.bsky.social · 10/06/2024
How can #spatial biology/tech help people living with cancer? In our review published #OpenAccess @SpringerNature we highlight the latest insights being made with #ST spatial transcriptomics in cancer #research! 🧬🔬 👉🔗 @ChrisSweens1 @LisaButler5
110
Michael Cilento @drcilento.bsky.social · 13/02/2024
Single-cell RNA sequencing of human prostate basal epithelial cells reveals zone-specific cellular populations…
000
Michael Cilento @drcilento.bsky.social · 28/11/2023
Great to see the power of #spatial being used in more comparative analyses (not just descriptive), like this #GeoMx data looking at unique features of CAFs in early onset CRC!
000
Michael Cilento @drcilento.bsky.social · 16/11/2023
Interesting big-picture perspective about the important issue of research biopsies, I’m always amazed by the altruism of people living with cancer in this space.
000
Michael Cilento @drcilento.bsky.social · 02/11/2023
Over $17K raised for SAiGENCI Cancer Research on #UoAGivingDay!! Huge thank you to everyone who contributed 🤩
000
Michael Cilento @drcilento.bsky.social · 30/10/2023
Proud to be an ambassador for @SAiGENCI Cancer Research this week! 🔬🧪🌟 You can have double the impact by donating tomorrow on #UofAGivingDay!! where all gifts this Tuesday will be matched up to $10,000!
000
Michael Cilento @drcilento.bsky.social · 24/10/2023
Excited to finally make my debut on X, as I delve into the world of #CancerResearch! 🔬🧬👨‍🔬
000